AI-designed universal coronavirus vaccine shows safety and immune response in first human trial
Summary
An AI-designed universal coronavirus vaccine developed by the University of Cambridge and DIOSynVax has successfully passed its first human clinical trial. The vaccine was found to be safe and well-tolerated in 39 healthy volunteers, generating immune responses against multiple coronaviruses including SARS-CoV-2, SARS, and related bat viruses. Unlike conventional vaccines targeting specific strains, this vaccine targets shared features across the Sarbeco coronavirus family, aiming to provide broad protection even as viruses evolve.
Source
bskyAI-designed universal coronavirus vaccine shows safety and immune response in first human trialshare.googleKey quotes
· 3 pulledThe experimental vaccine was found to be safe and caused no significant side effects in a study involving 39 healthy volunteers.
Unlike conventional vaccines that target specific virus strains, this vaccine was designed to protect against multiple members of the Sarbeco coronavirus family.
By targeting features shared across an entire virus family, it aims to provide protection even as viruses evolve.
You might also wanna read
SARS-CoV-2 RBD nanoparticle vaccine shows potent neutralization against variants in clinical studies
This article describes the characterization of a two-component protein nanoparticle vaccine platform (RBD-NP) that displays 60 copies of the
pmc.ncbi.nlm.nih.gov·4d ago
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac
med.stanford.edu·3mo ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
bbc.com·4mo ago
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·11mo ago
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·4d agoWhy COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·4d ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·10mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.